title: Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008.
abstract: We noted anecdotally that infections designated as health care-associated (HA-) MRSA by epidemiologic criteria seemed to be decreasing in incidence at the University of Chicago Medical Center (UCMC) after 2004. We compared MRSA patients seen at any site of clinical care at UCMC and the isolates that caused their infections in 2004-5 (n = 545) with those in 2008 (n = 135). The percent of patients with MRSA infections cultured > 2 days after hospital admission decreased from 19.5% in 2004-5 to 7.4% in 2008 (p = 0.001). The percent in 2004-5 compared with 2008 who had a hospitalization (49.1% to 26.7%, p = 0.001) or surgery (43.0% to 14.1%, p<0.001) in the previous year decreased. In 2008 a greater percent of patients was seen in the emergency department (23.1% vs. 39.3%) and a smaller percent both in intensive care units (15.6% vs. 6.7%) and in other inpatient units (40.7% vs. 32.6%) (p<0.001). The percent of patients with CA-MRSA infections by the CDC epidemiologic criteria increased from 36.5% in 2004-5 to 62.2% in 2008 (p<0.001). The percent of MRSA isolates sharing genetic characteristics of USA100 decreased from 27.9% (152/545) to 12.6% (17/135), while the percent with CA-MRSA (USA300) characteristics increased from 53.2% (290/545) to 66.7% (90/135). The percent of infections that were invasive did not change significantly. Our data suggest that HA-MRSA infections, both by epidemiologic and microbiologic criteria, relative to CA-MRSA, decreased between 2004-5 and 2008 at UCMC.
authors.affiliation: Department of Medicine, University of Chicago, Chicago, Illinois, United States of America; Department of Pediatrics, University of Chicago, Chicago, Illinois, United States of America.
authors.forename: Michael Z
authors.initials: MZ
authors.lastname: David
authors.affiliation: Department of Pediatrics, University of Chicago, Chicago, Illinois, United States of America.
authors.forename: Adriana
authors.initials: A
authors.lastname: Cadilla
authors.affiliation: Department of Pediatrics, University of Chicago, Chicago, Illinois, United States of America.
authors.forename: Susan
authors.initials: S
authors.lastname: Boyle-Vavra
authors.affiliation: Department of Pediatrics, University of Chicago, Chicago, Illinois, United States of America.
authors.forename: Robert S
authors.initials: RS
authors.lastname: Daum
mesh_terms: D000046:Academic Medical Centers; D000328:Adult; D002648:Child; D017714:Community-Acquired Infections / Q000453:epidemiology* / Q000382:microbiology*; D003695:Delivery of Health Care; D003710:Demography; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D015146:Midwestern United States; D010641:Phenotype; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology*
references.citation: Clin Infect Dis. 1999 Nov;29(5):1128-32
references.pmid: 10524952
references.citation: Clin Infect Dis. 2012 Jul;55(1):103-5
references.pmid: 22460965
references.citation: JAMA. 2010 Aug 11;304(6):641-8
references.pmid: 20699455
references.citation: Arch Intern Med. 2008 Jul 28;168(14):1585-91
references.pmid: 18663172
references.citation: N Engl J Med. 2006 Aug 17;355(7):666-74
references.pmid: 16914702
references.citation: Clin Infect Dis. 2011 Jul 15;53(2):144-9
references.pmid: 21690621
references.citation: Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164
references.pmid: 18068815
references.citation: Infect Control Hosp Epidemiol. 2012 Jul;33(7):725-31
references.pmid: 22669235
references.citation: Infection. 2012 Jun;40(3):291-7
references.pmid: 22161259
references.citation: Antimicrob Agents Chemother. 2012 Mar;56(3):1324-30
references.pmid: 22155818
references.citation: Public Health Rep. 2009 May-Jun;124(3):427-35
references.pmid: 19445419
references.citation: J Clin Microbiol. 2000 Mar;38(3):1008-15
references.pmid: 10698988
references.citation: J Clin Microbiol. 2005 Sep;43(9):4719-30
references.pmid: 16145133
references.citation: Antimicrob Agents Chemother. 2009 Dec;53(12):4961-7
references.pmid: 19721075
references.citation: Emerg Infect Dis. 2011 Mar;17(3):441-8
references.pmid: 21392435
references.citation: J Clin Microbiol. 2008 Jul;46(7):2345-52
references.pmid: 18508934
references.citation: Clin Infect Dis. 2006 Mar 1;42(5):647-56
references.pmid: 16447110
references.citation: Clin Microbiol Rev. 2010 Jul;23(3):616-87
references.pmid: 20610826
references.citation: Emerg Infect Dis. 2012 Jan;18(1):105-8
references.pmid: 22264651
references.citation: J Clin Microbiol. 2012 Jun;50(6):1950-7
references.pmid: 22422853
references.citation: Infect Control Hosp Epidemiol. 2010 Sep;31(9):983-5
references.pmid: 20677980
references.citation: J Infect Dis. 2008 May 1;197(9):1235-43
references.pmid: 18422435